Related Experiment Video
Updated: Aug 7, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Apocynin abrogates methotrexate-induced nephrotoxicity: role of TLR4/NF-κB-p65/p38-MAPK, IL-6/STAT-3, PPAR-γ, and
Emad H M Hassanein1, Ahmed M Sayed2, Omnia A M Abd El-Ghafar3
1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Azhar University, 71524, Asyut, Egypt.
Abstract:
The present study was designed to evaluate the potential renoprotective impacts of apocynin (APC) against nephrotoxicity induced by methotrexate (MTX) administration. To fulfill this aim, rats were allocated into four groups: control; APC (100 mg/kg/day; orally); MTX (20 mg/kg; single intraperitoneal dose at the end of the 5th day of the experiment); and APC +MTX (APC was given orally for 5 days before and 5 days after induction of renal toxicity by MTX). On the 11th day, samples were collected to estimate kidney function biomarkers, oxidative stress, pro-inflammatory cytokines, and other molecular targets. Compared to the MTX control group, treatment with APC significantly decreased urea, creatinine, and KIM-1 levels and improved kidney histological alterations. Furthermore, APC restored oxidant/antioxidant balance, as evidenced by a remarkable alleviation of MDA, GSH, SOD, and MPO levels. Additionally, the iNOS, NO, p-NF-κB-p65, Ace-NF-κB-p65, TLR4, p-p38-MAPK, p-JAK1, and p-STAT-3 expressions were reduced, while the IκBα, PPAR-γ, SIRT1, and FOXO3 expressions were significantly increased. In NRK-52E cells, MTX-induced cytotoxicity was protected by APC in a concentration-dependent manner. In addition, increased expression of p-STAT-3 and p-JAK1/2 levels were reduced in MTX-treated NRK-52E cells by APC. The in vitro experiments revealed that APC-protected MTX-mediated renal tubular epithelial cells were damaged by inhibiting the JAK/STAT3 pathway. Besides, our in vivo and in vitro results were confirmed by predicting computational pharmacology results using molecular docking and network pharmacology analysis. In conclusion, our findings proved that APC could be a good candidate for MTX-induced renal damage due to its strong antioxidative and anti-inflammatory bioactivities.
Insights
Apocynin (APC) protects against methotrexate (MTX)-induced kidney damage by reducing oxidative stress and inflammation. This study demonstrates APC
Area of Science:
- Pharmacology and Toxicology
- Nephrology
- Biochemistry
Background:
- Methotrexate (MTX) is a chemotherapy agent known to induce nephrotoxicity.
- Oxidative stress and inflammation are key mechanisms underlying MTX-induced kidney damage.
- Apocynin (APC) is an inhibitor of NADPH oxidase with potential antioxidant and anti-inflammatory properties.
Purpose of the Study:
- To evaluate the renoprotective effects of apocynin (APC) against methotrexate (MTX)-induced nephrotoxicity in a rat model.
- To investigate the underlying molecular mechanisms of APC's protective action, including its impact on oxidative stress, inflammation, and specific signaling pathways.
Main Methods:
- Rats were treated with APC, MTX, or a combination of both, with control groups included.
- Kidney function biomarkers (urea, creatinine, KIM-1), oxidative stress markers (MDA, GSH, SOD, MPO), and inflammatory markers (iNOS, NO, NF-κB, TLR4, JAK/STAT pathway) were assessed.
- In vitro studies using NRK-52E cells and computational pharmacology (molecular docking, network pharmacology) were employed to confirm findings.
Main Results:
- APC treatment significantly reduced MTX-induced increases in urea, creatinine, and KIM-1 levels, improving kidney histology.
- APC restored the oxidant/antioxidant balance and significantly reduced pro-inflammatory markers and expressions of iNOS, NF-κB, TLR4, p38-MAPK, JAK1, and STAT-3.
- APC protected renal tubular epithelial cells in vitro by inhibiting the JAK/STAT3 pathway, with findings supported by computational analyses.
Conclusions:
- Apocynin (APC) exhibits significant renoprotective effects against methotrexate (MTX)-induced nephrotoxicity.
- APC's protective mechanisms involve strong antioxidative and anti-inflammatory activities, including the inhibition of the JAK/STAT3 pathway.
- APC shows promise as a therapeutic candidate to mitigate MTX-induced renal damage.
More Related Videos
16:07Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody mAb by Neutralizing TNF Using an In Vitro Bioanalytical Method
Published on: September 16, 2017
06:12Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum
Published on: May 3, 2024
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
The JAK-STAT Signaling Pathway
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades
The Intrinsic Apoptotic Pathway